Home » Authors » Kim Coghill

Articles by Kim Coghill

Vasogen Given OK To Start Phase III Trial In Heart Failure

Nov. 20, 2002

Vasogen Given OK To Start Phase III Trial In Heart Failure

Nov. 20, 2002

ProdiGene's Transgenic Plants Cause Concern At USDA, FD

Nov. 19, 2002

ProdiGene's Transgenic Plants Cause Concern At USDA, FD

Nov. 19, 2002

NIH Awards Structural GenomiX Authority Over Protein Research

Nov. 18, 2002

NIH Awards Structural GenomiX Authority Over Protein Research

Nov. 18, 2002

Neurocrine Reports Positive Data From First Phase III Insomnia Trial

Nov. 15, 2002

Advisory Panel Unanimously Backs Roche's HCV Therapy

Nov. 15, 2002

Neurocrine Reports Positive Data From First Phase III Insomnia Trial

Nov. 15, 2002

Advisory Panel Unanimously Backs Roche's HCV Therapy

Nov. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...